NCT07818993

Brief Summary

This study evaluated whether a 2-week course of functional magnetic stimulation applied to the plantar region of the foot could improve sensory function, foot muscle force, postural control, and functional mobility in adults with type 2 diabetes mellitus and diabetic peripheral neuropathy. Participants were assigned to active functional magnetic stimulation or sham stimulation. The study hypothesis was that repeated functional magnetic stimulation would improve sensory and motor function and lead to better functional performance compared with sham stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 24, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 25, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 8, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 8, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

functional magnetic stimulationperipheral magnetic stimulationplantar sensationfoot strengthdiabetic peripheral neuropathyvibration perception

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in Timed Up and Go Completion Time

    Participants rose from a chair, walked 3.6 m, turned, walked back to the chair, and sat down. Completion time was recorded in seconds. Lower values indicate better functional mobility.

    Baseline and after 2 weeks of intervention (after 12 sessions)

  • Change From Baseline in Hallux Grip Force Assessed With the Enhanced Paper Grip Test

    Hallux grip force was measured in Newtons using the Enhanced Paper Grip Test. Three measurements were performed for each foot, and the outcome was the average across both feet and three trials. Higher values indicate greater foot grip force.

    Baseline and after 2 weeks of intervention (after 12 sessions)

Secondary Outcomes (3)

  • Change From Baseline in Center-of-Pressure Sway Velocity

    Baseline and after 2 weeks of intervention (after 12 sessions)

  • Change From Baseline in Semmes-Weinstein Monofilament Total Score

    Baseline and after 2 weeks of intervention (after 12 sessions)

  • Change From Baseline in Vibration Perception Threshold

    Baseline and after 2 weeks of intervention (after 12 sessions)

Study Arms (2)

Functional Magnetic Stimulation

EXPERIMENTAL

Participants received functional magnetic stimulation applied to the plantar region of the foot using the FMS Stym device. Treatment consisted of 12 sessions over 2 weeks, with each session lasting 20 minutes. The manufacturer's preset peripheral neuropathy program was used. Stimulation was continuous and intensity was individually adjusted to produce visible contractions of the intrinsic foot muscles while remaining comfortable.

Device: Functional Magnetic Stimulation

Sham Functional Magnetic Stimulation

SHAM COMPARATOR

Participants underwent the same positioning, treatment schedule, and session procedures as the active stimulation group. A metal plate was placed between the upper support plate and magnetic stimulation head to shield or substantially attenuate the magnetic field reaching the foot. Sessions lasted 20 minutes and were performed 12 times over 2 weeks.

Device: Sham Functional Magnetic Stimulation

Interventions

Pulsed magnetic stimulation was delivered to the plantar region of the foot using the FMS Stym device (Iskra Medical, Slovenia). Participants completed 12 sessions over 2 weeks, each lasting 20 minute

Functional Magnetic Stimulation

Sham treatment reproduced the positioning, appearance, schedule, and duration of active functional magnetic stimulation while a metal plate substantially attenuated the magnetic field reaching the foo

Sham Functional Magnetic Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with type 2 diabetes mellitus and diabetic peripheral polyneuropathy documented in their medical records
  • Ability to walk independently with or without an assistive device
  • Ability to understand and follow study procedures

You may not qualify if:

  • Conditions that could independently affect balance or foot function
  • Contraindications to magnetic stimulation
  • Active foot ulceration
  • Recent lower-limb injury or surgery
  • Severe neurological or musculoskeletal disease unrelated to diabetic peripheral neuropathy
  • Cognitive impairment preventing valid participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zdravstveni dom Koper

Koper, Urban Municipality of Koper, 6000, Slovenia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants in the sham group underwent the same positioning, session duration, and treatment procedures as participants receiving active stimulation. A metal plate was positioned between the support plate and magnetic stimulation head to shield or substantially attenuate the magnetic field while preserving the external appearance and procedural experience of treatment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

September 8, 2026

First Posted

September 14, 2026

Study Start

September 24, 2025

Primary Completion

March 30, 2026

Study Completion

April 25, 2026

Last Updated

September 14, 2026

Record last verified: 2026-09

Locations